Guideline on the evaluation of medicinal products indicated for treatment of bacterial infections, Rev. 3

As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to EMA in 2019 about Guideline on the evaluation of medicinal products indicated for treatment of bacterial infections, Rev. 3 can be found below.

Guideline on the evaluation of medicinal products indicated for treatment of bacterial infections, Rev. 3

Scroll to Top